Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Linc AB | 100,005 | net | 19 Dec 2023 | tx 2+100,005 |
| Enzymatica AB (publ) | 26,516 | net | 28 Nov 2018 | tx 2+26,516 |
| Recipharm AB | -4,800 | net | 15 Feb 2021 | tx 2+1,920−6,720 |
| Camurus AB | 4,512 | net | 25 Mar 2019 | tx 2+4,512 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Dec 2023 | PURCHASE | Linc AB | 100,000 | 59.00 SEK | first after silence |
| 16 Apr 2021 | PURCHASE | Linc AB | 5 | 190757.00 SEK | deriv |
| 15 Feb 2021 | SALE | Recipharm AB | 6,720 | 232.00 SEK | |
| 22 Jun 2020 | PURCHASE | Recipharm AB | 1,920 | 70.00 SEK | first after silence |
| 25 Mar 2019 | PURCHASE | Camurus AB | 3,012 | 42.00 SEK | |
| 28 Nov 2018 | GRANT_AWARD | Enzymatica AB (publ) | 4 | 0.00 SEK | deriv |
| 28 Nov 2018 | PURCHASE | Enzymatica AB (publ) | 26,512 | 1.90 SEK | |
| 15 Mar 2018 | PURCHASE | Camurus AB | 1,500 | 113.80 SEK |
2 purchases reported after at least 12 months of silence — most recent on 19 Dec 2023.